MCH ANALYSIS RESEARCHMain site ↗
Industrials

Aerospace & Defense

22 companies under coverage.

Coverage

Aerospace & Defense


Equity Research

Curtiss-Wright Corporation (CW)

BUY. 12-month probability-weighted target $693 (+35% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

CWEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +10.8%
Equity Research

Parsons Corp (PSN)

BUY. 12-month probability-weighted target $55 (+22% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

PSNEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +9.4%
Equity Research

StandardAero, Inc. (SARO)

BUY. 12-month probability-weighted target $26 (+27% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

SAROEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +5.0%
Equity Research

L3Harris Technologies Inc (LHX)

BUY. 12-month probability-weighted target $283 (+19% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

LHXEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +4.8%
Equity Research

Textron Inc (TXT)

HOLD. 12-month probability-weighted target $81 (+9% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

TXTEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price +3.4%
Equity Research

BWX Technologies Inc (BWXT)

BUY. 12-month probability-weighted target $168 (+17% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

BWXTEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +2.6%
Equity Research

Honeywell Aerospace Inc (HONA)

BUY. 12-month probability-weighted target $213 (+35% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

HONAEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +1.0%
Equity Research

Transdigm Group Incorporated (TDG)

HOLD. 12-month probability-weighted target $1273 (+15% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TDGEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -1.0%
Equity Research

Moog Inc (MOG-A)

HOLD. 12-month probability-weighted target $390 (+7% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

MOG-AEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -1.1%
Equity Research

Hexcel Corporation (HXL)

HOLD. 12-month probability-weighted target $104 (+22% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

HXLEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -3.9%
Equity Research

General Dynamics Corporation (GD)

HOLD. 12-month probability-weighted target $337 (+2% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

GDEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -4.3%
Equity Research

GE Aerospace (GE)

HOLD. 12-month probability-weighted target $338 (+10% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

GEEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -4.4%
Equity Research

RTX Corporation (RTX)

HOLD. 12-month probability-weighted target $186 (+0% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

RTXEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -6.1%
Equity Research

Karman Holdings Inc. (KRMN)

HOLD. 12-month probability-weighted target $34 (+5% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

KRMNEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -6.4%
Equity Research

Lockheed Martin Corporation (LMT)

HOLD. 12-month probability-weighted target $481 (-6% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

LMTEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -10.6%
Equity Research

Howmet Aerospace Inc (HWM)

HOLD. 12-month probability-weighted target $251 (+11% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HWMEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -11.7%
Equity Research

Northrop Grumman Corporation (NOC)

HOLD. 12-month probability-weighted target $488 (+2% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

NOCEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -12.3%
Equity Research

Huntington Ingalls Industries Inc (HII)

HOLD. 12-month probability-weighted target $269 (+2% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

HIIEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -12.6%
Equity Research

Allegheny Technologies Incorporated (ATI)

HOLD. 12-month probability-weighted target $181 (-5% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

ATIEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -15.2%
Equity Research

AeroVironment Inc (AVAV)

HOLD. 12-month probability-weighted target $142 (+3% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

AVAVEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -15.7%
Equity Research

Axon Enterprise Inc. (AXON)

HOLD. 12-month probability-weighted target $449 (+6% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

AXONEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -18.0%
Equity Research

Kratos Defense & Security Solutions (KTOS)

SELL. 12-month probability-weighted target $34 (-19% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

KTOSEquity ResearchMonte Carlo
12 October 2026Rating: SELL · Fair value vs price -33.6%
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies